Return
Accelerating Drug Development Using Spatial Multi-omics
DOI:10.1158/2159-8290.CD-24-0101.png)
Abstract
En 中文
Spatial biology approaches enabled by innovations in imaging biomarker platforms and artificial intelligence-enabled data integration and analysis provide an assessment of patient and disease heterogeneity at ever-increasing resolution. The utility of spatial biology data in accelerating drug programs, however, requires balancing exploratory discovery investigations against scalable and clinically applicable spatial biomarker analysis.
Keywords:
ARTIFICIAL-INTELLIGENCE
Journal
IF:
33.3
Papers:
3.9K
Citations:
3.7W
Organization
Cited Papers
Whole-genome and transcriptome analysis enhances precision cancer treatment options
ANNALS OF ONCOLOGY
IF65.4
Artificial intelligence in histopathology: enhancing cancer research and clinical oncology
NATURE CANCER
IF28.5
Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer
CANCER DISCOVERY
IF33.3

